Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: max who wrote (3377)	6/23/1998 10:24:00 AM
From: BuzzVA	Respond to of 5736

Taken from the SPRX thread. Was this poster wrong about SPRX too, if in fact these tests will not be covered by insurance? ---------------------------------------------------------------------- To: +Robin (10 ) From: +Cacaito Thursday, May 14 1998 11:22AM ET Reply # of 13 I tested both Bilicheck on myself and friends, and CCSI (Colormate?) at the New Orleans meeting of the Pediatric Research Societies (May 1 to 5) and did not find any major difference between them in terms of technology or ease of use. The Bilicheck has a small extra piece for control (and it costs some additional money). Both will sell in the $3,000 range. Patient bill expenses will be covered by insurance companies for both (very important). There were several poster presentations about the use of both instruments with good results in newborn babies. Respironics booth was also promoting Bilicheck at the meeting in New Orleans.

To: max who wrote (3377)	6/23/1998 10:25:00 AM
From: Mama Bear	Read Replies (2) \| Respond to of 5736

Let's see, you claim I am a "manipulator"? Do you care to back up that libelous and totally untrue statement? That I am short is no reason. There are longs here who stand to profit from the rise, why don't you call them manipulators? Do you really believe that a person couldn't look at the same set of circumstances and come up with a conclusion to the company line? My question to you is, "Why would an insider sell even a single share, if the stock they are holding has even 1/2 the potential as claimed by CCSI?" And you must be looking at a different chart than I am, I show CCSI near it's highs all through the time the insiders were selling. >>>Until then, drop the hype, and stick to facts.<<< I'd suggest you learn what hype is. You might study Skipard's posts for a case study. Barb